fda warnings bpc-157 warning 2025 september The Hidden Risks of BPC‑157: What Patients Need fda warning bpc-157 unapproved peptide
Description
1 Introduction In vivo therapy based on monoclonal antibodies (mAbs) represents the natural extension of their widespread use in vitro

SCFAs, such as butyrate, act as energy sources for colonic epithelium

For example, proton pump inhibitors (PPIs) and H2 receptor antagonists, commonly used to treat gastroesophageal reflux disease (GERD), can reduce the absorption of vitamin B12 and may necessitate adjustments in the dosing of methylcobalamin

Indeed, one pharmacy (unrelated to BPC specifically) was hit with FDA warnings for sterility problems in its peptide injectable products

Rasmussen believes people would still misconstrue the science regardless, particularly with leaders in the Trump administration who have spent years undermining the safety of vaccines or have a history of promoting dubious supplements